Loading...
Docoh

Biolife Solutions (BLFS)

Employees
Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On June 18, 2021, BioLife Solutions, Inc. (the “Company”) completed its 2021 annual meeting of stockholders (the “Annual Meeting”). The number of shares of stock entitled to vote at the Annual Meeting was 34,773,060 consisting of 33,718,859 shares of common stock and 1,054,201 shares of unvested restricted stock (collectively, the “Voting Stock”). The number of shares of Voting Stock present or represented by valid proxy at the Annual Meeting was 19,951,001 shares. At the Annual Meeting, the Company’s stockholders (i) re-elected each of Michael Rice, Raymond W. Cohen, Andrew Hinson, Joseph Schick, Amy Duross and Rachel Ellingson as directors, (ii) approved, on a non-binding, advisory basis, the Company’s executive compensation, and (iii) approved an amendment to the Second Amended and Restated 2013 Performance Incentive Plan to increase the aggregate number of shares of common stock which may be issued under the plan from 5,000,000 to 6,500,000 shares. The following is a tabulation of the voting on the proposals presented at the Annual Meeting:

Proposal No. 1 – Election of directors

Michael Rice, Raymond W. Cohen, Andrew Hinson, Joseph Schick, Amy Duross, and Rachel Ellingson were elected to serve until the 2022 annual meeting of stockholders or until their successors are elected and qualified or until their earlier resignation or removal. The voting results were as follows:

NomineeShares Voted ForShares WithheldBroker Non-Vote
Michael Rice19,779,345171,6560
Raymond W. Cohen19,459,325491,6760
Andrew Hinson19,193,703757,2980
Joseph Schick17,226,3532,724,6480
Amy Duross19,913,36037,6410
Rachel Ellingson19,804,907146,0940


Proposal No. 2 – Approval, by non-binding advisory vote, of the Company’s executive compensation

The Company’s executive compensation, by non-binding advisory vote, was approved. The voting results were as follows:

Votes ForVotes AgainstAbstentionsBroker Non-Votes
14,145,5475,782,63522,8190

Proposal No. 3 – Approval of amendment to the Second Amended and Restated 2013 Performance Incentive Plan to increase the aggregate number of shares of common stock which may be issued under the plan from 5,000,000 to 6,500,000 shares

The Amendment to the Second Amended and Restated 2013 Performance Incentive Plan to increase the aggregate number of shares of common stock which may be issued under the plan from 5,000,000 to 6,500,000 shares was approved. The voting results were as follows:

Shares Voted ForShares Voted AgainstShares AbstainingBroker Non-Vote
18,427,2901,504,67319,0380